Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
26 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
August 28, 2025
Extension Available
Until August 29, 2024
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 27, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 26, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 26, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 1, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 1, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 1, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 1, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 12, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 29, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 14, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 31, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 14, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 25, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of graft versus host disorders
Class 044
Providing healthcare information to physicians, patients and caregivers relating to diagnosis and treatment of medical diseases and disorders
Classification
International Classes
005
044